OA02.03 The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
Year: 2019
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: S. Lu, Q. Wang, G. Zhang, X. Dong, C. Yang, Y. Song, G. Chang, Y. Lu, H. Pan, C. Chiu, Z. Wang, J. Feng, J. Zhou, X. Xu, R. Guo, J. Chen, H. Yang, Y. Chen, Z. Yu, H. Shiah, C. Wang, N. Yang, J. Fang, P. Wang, K. Wang, Y. Hu, J. He, Z. Wang, J. Shi, S. Chen, Y. Cheng, W. Su, T. Hsia, J. Cui, Y. Sun, C. Yang
Institutions: Shanghai Chest Hospital, Zhengzhou University, Henan Cancer Hospital, First Affiliated Hospital of Zhengzhou University, Wuhan Union Hospital, Huazhong University of Science and Technology, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, National Taiwan University Hospital, Nanjing General Hospital of Nanjing Military Command, Taichung Veterans General Hospital, Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy, Sir Run Run Shaw Hospital, Taipei Veterans General Hospital, Peking University Cancer Hospital, Shandong Tumor Hospital, Jiangsu Cancer Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Jiangsu Province Hospital, Hunan Cancer Hospital, Wenzhou Medical University, Affiliated Hospital of Qingdao University, Taipei Medical University Hospital, Kaohsiung Chang Gung Memorial Hospital, Second Affiliated Hospital of Zhejiang University, Hubei Cancer Hospital, First Affiliated Hospital of Guangzhou Medical University, Binzhou Medical University, Jilin Province Tumor Hospital, National Cheng Kung University Hospital, First Hospital of Jilin University, Jinan Central Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2981598927